Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12–15 December 2017, Miami, FL, USA

by Christina K. Psomas, Alain Lafeuillade, David Margolis, Karl Salzwedel, Mario Stevenson, Nicolas Chomont, Guido Poli, Jean-Pierre Routy
Published 2018-04-01

Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10–13 December 2019, Miami, USA

by ChristinaK Psomas, Karl Salzwedel, Mario Stevenson, Guido Poli, Jean-Pierre Routy, David Margolis, Nicolas Chomont, Alain Lafeuillade
Published 2020-04-01

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spai...

by Deanna Kerrigan, Andrea Mantsios, Miguel Gorgolas, Maria-Luisa Montes, Federico Pulido, Cynthia Brinson, Jerome deVente, Gary J Richmond, Sarah W Beckham, Paige Hammond, David Margolis, Miranda Murray
Published 2018-01-01

Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.

by Cynthia Gay, Oliver Dibben, Jeffrey A Anderson, Andrea Stacey, Ashley J Mayo, Philip J Norris, JoAnn D Kuruc, Jesus F Salazar-Gonzalez, Hui Li, Brandon F Keele, Charles Hicks, David Margolis, Guido Ferrari, Barton Haynes, Ronald Swanstrom, George M Shaw, Beatrice H Hahn, Joseph J Eron, Persephone Borrow, Myron S Cohen
Published 2011-05-01

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

by Raphael J Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Y Liu, Manya Magnus, Mina C Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A Marzinke, Craig W Hendrix, Susan H Eshleman, Yinfeng Zhang, Elizabeth Tolley, Jeremy Sugarman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R Rinehart, David Margolis, William R Spreen, Myron S Cohen, Marybeth McCauley, Joseph J Eron
Published 2018-11-01